Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Biowaiver monographs for immediate release solid oral dosage forms: lamivudine.

Strauch S, Jantratid E, Dressman JB, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM.

J Pharm Sci. 2011 Jun;100(6):2054-63. doi: 10.1002/jps.22449. Review.

PMID:
21491435
2.

Biowaiver monographs for immediate-release solid oral dosage forms: ketoprofen.

Shohin IE, Kulinich JI, Ramenskaya GV, Abrahamsson B, Kopp S, Langguth P, Polli JE, Shah VP, Groot DW, Barends DM, Dressman JB.

J Pharm Sci. 2012 Oct;101(10):3593-603. doi: 10.1002/jps.23233. Review.

PMID:
22786667
3.

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Levetiracetam.

Petruševska M, Berglez S, Krisch I, Legen I, Megušar K, Peternel L, Abrahamsson B, Cristofoletti R, Groot DW, Kopp S, Langguth P, Mehta M, Polli JE, Shah VP, Dressman J.

J Pharm Sci. 2015 Sep;104(9):2676-87. doi: 10.1002/jps.24350. Review.

PMID:
25663270
4.

Biowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochloride.

Olivera ME, Manzo RH, Junginger HE, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM.

J Pharm Sci. 2011 Jan;100(1):22-33. doi: 10.1002/jps.22259. Review.

PMID:
20602455
5.

Biowaiver monographs for immediate release solid oral dosage forms: Doxycycline hyclate.

Jantratid E, Strauch S, Becker C, Dressman JB, Amidon GL, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM.

J Pharm Sci. 2010 Apr;99(4):1639-53. doi: 10.1002/jps.21954. Review.

6.

Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride.

Strauch S, Jantratid E, Dressman JB, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Barends DM.

J Pharm Sci. 2011 Jan;100(1):11-21. doi: 10.1002/jps.22249. Review.

PMID:
20602454
7.

Biowaiver monographs for immediate release solid oral dosage forms: efavirenz.

Cristofoletti R, Nair A, Abrahamsson B, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Dressman JB.

J Pharm Sci. 2013 Feb;102(2):318-29. doi: 10.1002/jps.23380. Review.

PMID:
23175470
8.

Biowaiver monographs for immediate-release solid oral dosage forms: Zidovudine (azidothymidine).

Soares KC, Rediguieri CF, Souza J, Serra CH, Abrahamsson B, Groot DW, Kopp S, Langguth P, Polli JE, Shah VP, Dressman J.

J Pharm Sci. 2013 Aug;102(8):2409-23. doi: 10.1002/jps.23624. Review.

PMID:
23754446
9.

Biowaiver monographs for immediate release solid oral dosage forms: prednisolone.

Vogt M, Derendorf H, Krämer J, Junginger HE, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM.

J Pharm Sci. 2007 Jan;96(1):27-37. Review.

PMID:
17039494
10.

Biowaiver monographs for immediate release solid oral dosage forms: amodiaquine hydrochloride.

Nair A, Abrahamsson B, Barends DM, Groot DW, Kopp S, Polli JE, Shah VP, Dressman JB.

J Pharm Sci. 2012 Dec;101(12):4390-401. doi: 10.1002/jps.23312. Review.

PMID:
22949374
11.

The biopharmaceutics classification system (BCS): class III drugs - better candidates for BA/BE waiver?

Blume HH, Schug BS.

Eur J Pharm Sci. 1999 Dec;9(2):117-21. Review.

PMID:
10620723
12.

Biowaiver: an alternative to in vivo pharmacokinetic bioequivalence studies.

Mishra V, Gupta U, Jain NK.

Pharmazie. 2010 Mar;65(3):155-61. Review.

PMID:
20383933
13.

The impact of the EMA change in definition of "dose" on the BCS dose-solubility ratio: a review of the biowaiver monographs.

Sediq A, Kubbinga M, Langguth P, Dressman J.

J Pharm Sci. 2014 Jan;103(1):65-70. doi: 10.1002/jps.23769. Review.

PMID:
24338749
14.

Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs.

Dahan A, Miller JM, Amidon GL.

AAPS J. 2009 Dec;11(4):740-6. doi: 10.1208/s12248-009-9144-x. Review.

15.

The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.

Lennernäs H, Abrahamsson B.

J Pharm Pharmacol. 2005 Mar;57(3):273-85. Review.

PMID:
15807982
16.
17.

Impact of osmotically active excipients on bioavailability and bioequivalence of BCS class III drugs.

Chen ML, Sadrieh N, Yu L.

AAPS J. 2013 Oct;15(4):1043-50. doi: 10.1208/s12248-013-9509-z. Review. No abstract available.

18.

[Biopharmaceutical classification system--experimental model of the prediction of drug bioavailability].

Golovenko NIa, Borisiuk IIu.

Biomed Khim. 2008 Jul-Aug;54(4):392-407. Review. Russian.

PMID:
18988456
19.

Biowaivers for oral immediate-release products: implications of linear pharmacokinetics.

Faassen F, Vromans H.

Clin Pharmacokinet. 2004;43(15):1117-26. Review.

PMID:
15568890
20.

A science based approach to topical drug classification system (TCS).

Shah VP, Yacobi A, Rădulescu FŞ, Miron DS, Lane ME.

Int J Pharm. 2015 Aug 1;491(1-2):21-5. doi: 10.1016/j.ijpharm.2015.06.011. Review.

PMID:
26070249
Items per page

Supplemental Content

Support Center